In situ sequencing also confirmed a consistent pattern: in EpCAMhigh tumor cell-dominated spots, compared to EpCAM-negative cell-dominated spots, there was a more frequent expression of the CD133/PROM1 gene along with the transcription factor genes OCT4/POU5F1, KLF4, and MYC. The gene discussed is PROM1; the disease is neoplasm.